These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1421 related articles for article (PubMed ID: 33738432)

  • 1. SARS-CoV-2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice.
    Ma Y; Lu D; Bao L; Qu Y; Liu J; Qi X; Yu L; Zhang X; Qi F; Lv Q; Liu Y; Shi X; Sun C; Li J; Wang J; Han Y; Gao K; Dong W; Liu N; Gao S; Xue J; Wei Q; Pan S; Gao H; Zhang L; Qin C
    Animal Model Exp Med; 2021 Mar; 4(1):2-15. PubMed ID: 33738432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss.
    Behera J; Ison J; Voor MJ; Tyagi SC; Tyagi N
    Biochem Biophys Res Commun; 2022 Sep; 620():180-187. PubMed ID: 35803174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
    Seeherman S; Suzuki YJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
    J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-infection effects of heparin on SARS-CoV-2 in a diabetic mouse model.
    Zhang Z; Zhang N; Lu X; Zhou M; Yan X; Gu W; Yang J; Zhang Q; Zhang C; Gong Y; Jia M; Zhang X; Ning P; Liu M; Li X; Shi X; Liu W; Gao GF; Ning G; Wang J; Bi Y
    Zool Res; 2023 Nov; 44(6):1003-1014. PubMed ID: 37759335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy.
    Xie L; Zhang Z; Wang Q; Chen Y; Lu D; Wu W
    Front Endocrinol (Lausanne); 2021; 12():772865. PubMed ID: 34867819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.
    Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A
    Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible consequences of Covid-19 on the nervous system.
    Sramka M; Slavik J; Masan J; Ruzicky E
    Neuro Endocrinol Lett; 2020 Oct; 41(4):166-172. PubMed ID: 33307651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
    Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
    Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
    Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
    Dolan ME; Hill DP; Mukherjee G; McAndrews MS; Chesler EJ; Blake JA
    Sci Rep; 2020 Nov; 10(1):20848. PubMed ID: 33257774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients.
    Kumar A; Faiq MA; Pareek V; Raza K; Narayan RK; Prasoon P; Kumar P; Kulandhasamy M; Kumari C; Kant K; Singh HN; Qadri R; Pandey SN; Kumar S
    Med Hypotheses; 2020 Nov; 144():110271. PubMed ID: 33254575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
    Groß S; Jahn C; Cushman S; Bär C; Thum T
    J Mol Cell Cardiol; 2020 Jul; 144():47-53. PubMed ID: 32360703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and inflammatory health in SARS-CoV-2 and the potential role for habitual exercise in reducing disease severity.
    Marino FE; Vargas NT; Skein M; Hartmann T
    Inflamm Res; 2022 Jan; 71(1):27-38. PubMed ID: 34719732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
    Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY
    Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»).
    Tarlovskaya EI; Arutyunov AG; Konradi AO; Lopatin YM; Rebrov AP; Tereshchenko SN; Chesnikova AI; Hayrapetyan HG; Babin AP; Bakulin IG; Bakulina NV; Balykova LA; Blagonravova AS; Boldina MV; Vaisberg AR; Galyavich AS; Gomonova VV; Grigorieva NY; Gubareva IV; Demko IV; Evzerikhina AV; Zharkov AV; Kamilova UK; Kim ZF; Kuznetsova TY; Lareva NV; Makarova EV; Malchikova SV; Nedogoda SV; Petrova MM; Pochinka IG; Protasov KV; Protsenko DN; Ruzanau DY; Sayganov SA; Sarybaev AS; Selezneva NM; Sugraliev AB; Fomin IV; Khlynova OV; Chizhova OY; Shaposhnik II; Shсukarev DA; Abdrahmanova AK; Avetisian SA; Avoyan HG; Azarian KK; Aimakhanova GT; Ayipova DA; Akunov AC; Alieva MK; Aparkina AV; Aruslanova OR; Ashina EY; Badina OY; Barisheva OY; Batchayeva AS; Bitieva AM; Bikhteyev IU; Borodulina NA; Bragin MV; Budu AM; Burygina LA; Bykova GA; Vagapova KR; Varlamova DD; Vezikova NN; Verbitskaya EA; Vilkova OE; Vinnikova EA; Vustina VV; Gаlova EA; Genkel VV; Gorshenina EI; Gostishev RV; Grigorieva EV; Gubareva EY; Dabylova GM; Demchenko AI; Dolgikh OY; Duyshobayev MY; Evdokimov DS; Egorova KE; Ermilova AN; Zheldybayeva AE; Zarechnova NV; Zimina YD; Ivanova SY; Ivanchenko EY; Ilina MV; Kazakovtseva MV; Kazymova EV; Kalinina YS; Kamardina NA; Karachenova AM; Karetnikov IA; Karoli NA; Karpov OV; Karsiev MK; Кaskaeva DS; Kasymova KF; Kerimbekova ZB; Kerimova AS; Kim ES; Kiseleva NV; Klimenko DA; Klimova AV; Kovalishena OV; Kolmakova EV; Kolchinskaya TP; Kolyadich MI; Kondriakova OV; Konoval MP; Konstantinov DY; Konstantinova EA; Kordukova VA; Koroleva EV; Kraposhina AY; Kriukova TV; Kuznetsova AS; Kuzmina TY; Kuzmichev KV; Kulchoroeva CK; Kuprina TV; Kouranova IM; Kurenkova LV; Kurchugina NY; Kushubakova NA; Levankova VI; Levin MЕ; Lyubavina NA; Magdeyeva NA; Mazalov KV; Majseenko VI; Makarova AS; Maripov AM; Marusina AA; Melnikov ES; Moiseenko NB; Muradova FN; Muradyan RG; Myshak AO; Nikitina NM; Ogurlieva BB; Odegova AA; Omarova YM; Omurzakova NA; Ospanova SO; Pahomova EV; Petrov LD; Plastinina SS; Pogrebetskaya VA; Polyakov DS; Ponomarenko EV; Popova LL; Prokofeva NA; Pudova IA; Rakov NA; Rakhimov AN; Rozanova NA; Serikbolkyzy S; Simonov AA; Skachkova VV; Soloveva DV; Soloveva IA; Sokhova FM; Subbotin AK; Sukhomlinova IM; Sushilova AG; Tagayeva DR; Titojkina YV; Tikhonova EP; Tokmin DS; Tolmacheva AA; Torgunakova MS; Trenogina KV; Trostianetckaia NA; Trofimov DA; Tulichev AA; Tursunova AT; Ulanova ND; Fatenkov OV; Fedorishina OV; Fil TS; Fomina IY; Fominova IS; Frolova IA; Tsvinger SM; Tsoma VV; Cholponbaeva MB; Chudinovskikh TI; Shevchenko OA; Sheshina TV; Shishkina EA; Shishkov KY; Sherbakov SY; Yausheva EA; Musaelian SN; Belenkov YN; Arutyunov GP
    Kardiologiia; 2021 Sep; 61(9):20-32. PubMed ID: 34713782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19.
    Smith SM; Boppana A; Traupman JA; Unson E; Maddock DA; Chao K; Dobesh DP; Brufsky A; Connor RI
    J Med Virol; 2021 Jan; 93(1):409-415. PubMed ID: 32589756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.